SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-004049
Filing Date
2020-11-20
Accepted
2020-11-20 16:12:04
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_10q-093020.htm 10-Q 548858
2 CERTIFICATION sonoma_ex3101.htm EX-31.1 8473
3 CERTIFICATION sonoma_ex3102.htm EX-31.2 8421
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 5439
  Complete submission text file 0001683168-20-004049.txt   3336900

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20200930.xml EX-101.INS 596090
6 XBRL SCHEMA FILE snoa-20200930.xsd EX-101.SCH 31966
7 XBRL CALCULATION FILE snoa-20200930_cal.xml EX-101.CAL 60914
8 XBRL DEFINITION FILE snoa-20200930_def.xml EX-101.DEF 110251
9 XBRL LABEL FILE snoa-20200930_lab.xml EX-101.LAB 281494
10 XBRL PRESENTATION FILE snoa-20200930_pre.xml EX-101.PRE 228996
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 201332631
SIC: 2834 Pharmaceutical Preparations